The Temperature Controlled Pharmaceutical Packaging Solutions Market Size is valued at USD 5.17 Bn in 2023 and is predicted to reach USD 8.64 Bn by the year 2031 at an 6.7% CAGR during the forecast period for 2024-2031.
Temperature Controlled Pharmaceutical Packaging Solutions refer to specialized packaging systems designed to maintain the required temperature range for pharmaceutical products during storage and transportation. These solutions are critical for preserving the integrity, efficacy, and safety of temperature-sensitive medications, such as vaccines, biologics, and other pharmaceutical products. They use materials with high thermal resistance to protect products from temperature fluctuations and active temperature control systems like refrigerated containers or coolers to provide a constant temperature. Electronic systems provide precise temperature control through refrigeration or heating mechanisms. These packaging solutions are essential for ensuring that pharmaceuticals remain effective from the point of manufacture to the end user, particularly in global distribution where products may encounter varying climatic conditions.
The market for temperature-controlled packaging solutions is expanding significantly due to increased demand from the food, pharmaceutical, and healthcare industries. The integrity and security of temperature-sensitive goods during storage and transportation are dependent on these businesses' use of efficient packaging solutions. Strict legal requirements for product safety and quality, new developments in insulating materials, and the growing demand for cold chain logistics are some of the main motivators. The market is expanding as a result of advancements in biodegradable materials and smart packaging technologies, which provide long-term answers to environmental issues on a worldwide scale.
The is segmented based on product type, temperature range and application, and by region. By Product type, the market is segmented into insulated shippers, insulated protective shippers, and insulated containers. Insulated Shippers segmented into panels & envelopes, EPS foam containers, fibreboard, and PUR containers. Insulated Containers are segmented into chest style, upright style, and others. Temperature Range segment includes -20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C. By application, the market is segmented into frozen, chilled, and ambient.
Based on the product type, the market is divided into insulated shippers, insulated protective shippers, and insulated containers. Insulated Shippers segmented into panels & envelopes, EPS foam containers, fibreboard, and PUR containers. Insulated Containers are segmented into chest style, upright style, and others. Among these, The Insulated Containers segment is expected to have the highest growth rate during the forecast period. They offer significant capacity for storing and transporting pharmaceuticals, vaccines, and biologics in bulk. Used extensively in cold chain logistics for pharmaceutical distribution, especially for long-distance transport where maintaining temperature integrity is critical. The demand for insulated containers is driven by the expansion of biopharmaceuticals, vaccines, and specialty drugs that require stringent temperature control.
Based on the application, the market is categorized into frozen, chilled, and ambient. Among these, the chilled segment dominates the market. This segment caters to pharmaceutical products that require storage and transportation at temperatures typically ranging from 2°C to 8°C. Many biologics, vaccines, and specialty drugs fall into this category. The growth in biopharmaceuticals and vaccines, which often require chilled storage to maintain efficacy and safety, drives demand for sophisticated temperature-controlled packaging solutions.
The Asia Pacific region is experiencing rapid economic growth, leading to increased healthcare spending and infrastructure development. This growth supports the demand for pharmaceutical products, including biologics, vaccines, and specialty drugs that require stringent temperature control. With a growing population and rising healthcare awareness, there is a heightened demand for vaccines and biologics across Asia Pacific. These products are highly sensitive to temperature variations and require reliable temperature-controlled packaging solutions.
Report Attribute |
Specifications |
Market Size Value In 2023 |
USD 5.17 Bn |
Revenue Forecast In 2031 |
USD 8.64 Bn |
Growth Rate CAGR |
CAGR of 6.7% from 2024 to 2031 |
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Product type, Temperature Range, Application, |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
Competitive Landscape |
Sonoco Products Company, Pelican Biothermal, Sofrigam SA Ltd., Cryopak, Cold Chain Technologies, Envirotainer Ltd., Cencora Inc., Inmark Packaging, American Aerogel Corporation |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Temperature Controlled Pharmaceutical Packaging Solutions Market Snapshot
Chapter 4. Global Temperature Controlled Pharmaceutical Packaging Solutions Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Insulated Shippers
5.2.1.1. Panels & Envelopes
5.2.1.2. EPS Foam Containers
5.2.1.3. Fibreboard
5.2.1.4. PUR Containers
5.2.2. Insulated Protective Shippers
5.2.3. Insulated Containers
5.2.3.1. Chest Style
5.2.3.2. Upright Style
5.2.3.3. Others
Chapter 6. Market Segmentation 2: by Temperature Range Estimates & Trend Analysis
6.1. by Temperature Range & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Temperature Range:
6.2.1. -20°C AND BELOW
6.2.2. -20°C TO 0°C
6.2.3. 2°C TO 8°C
6.2.4. 8°C TO 25°C
6.2.5. ABOVE 25°C
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Frozen
7.2.2. Chilled
7.2.3. Ambient
Chapter 8. Temperature Controlled Pharmaceutical Packaging Solutions Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.1.2. North America Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Temperature Range, 2024-2031
8.1.3. North America Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.4. North America Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.2.2. Europe Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Temperature Range, 2024-2031
8.2.3. Europe Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. Europe Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.3.2. Asia Pacific Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Temperature Range, 2024-2031
8.3.3. Asia Pacific Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Asia Pacific Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.4.2. Latin America Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Temperature Range, 2024-2031
8.4.3. Latin America Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Latin America Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.5.2. Middle East & Africa Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Temperature Range, 2024-2031
8.5.3. Middle East & Africa Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Middle East & Africa Temperature Controlled Pharmaceutical Packaging Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Aeris Dynamics
9.2.2. American Aerogel Corporation
9.2.3. Amerisourcebergen Corporation
9.2.4. Cardinal Health, Inc.
9.2.5. Cencora Inc.
9.2.6. Cold Chain Technologies, Llc
9.2.7. Cryopak Industries Inc.
9.2.8. Cryoport, Inc.
9.2.9. Csafe Global, Llc
9.2.10. Deutsche Bahn Ag
9.2.11. DGP Intelsius Gmbh
9.2.12. DHL International Gmbh
9.2.13. Ecocool Gmbh
9.2.14. Emball’iso
9.2.15. Envirotainer Ab
9.2.16. Exeltainer Sl
9.2.17. Fedex Corporation
9.2.18. Inmark Packaging
9.2.19. Insulated Products Corporation
9.2.20. Kaneka Corporation
9.2.21. Kuehne + Nagel Inc.
9.2.22. Mckesson Corporation
9.2.23. Pelican Biothermal
9.2.24. Sealed Air Corporation
9.2.25. Sofrigam Sa Ltd.
9.2.26. Softbox Systems
9.2.27. Sonoco Products Company
9.2.28. United Parcel Service America, Inc
9.2.29. Va Q Tec Ag
9.2.30. Other Prominent Players
Global Temperature Controlled Pharmaceutical Packaging Solutions Market, By Product Type
Global Temperature Controlled Pharmaceutical Packaging Solutions Market – By Temperature Range
Global Temperature Controlled Pharmaceutical Packaging Solutions Market – By Application
Global Temperature Controlled Pharmaceutical Packaging Solutions Market – By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.